BioCentury | May 16, 2011
Company News

Fluidigm sales and marketing update

Fluidigm launched its DELTAgene Assays for gene and single-cell expression, SNPtype Assays for SNP genotyping and target-specific primers for targeted resequencing worldwide. Fluidigm Corp. (NASDAQ:FLDM), South San Francisco, Calif. Business: Genomics WIR Staff...
BioCentury | Dec 21, 2009
Company News

Benten BioServices Inc., Deltagen deal

...Drug discovery company Deltagen acquired contract service company Benten in a stock deal valued at $1.1...
...acquired contract service company Benten in a stock deal valued at $1.1 million based on Deltagen's...
...close of $0.12 on Dec. 9, the last trading day before the deal was announced. Deltagen...
BioCentury | Mar 16, 2007
Company News

Roche returns rights to Trimeris' fusion inhibitor IP

...named E. Lawrence Hill acting president and COO. Hill is former CEO of genomics company Deltagen...
BioCentury | Apr 3, 2006
Company News

Deltagen board of directors update

Deltagen Inc. (DGEN), San Carlos, Calif. Business: Genomics, Functional genomics Appointed: Robert Driscoll, president, CEO and secretary; Philippe Chambon, a managing director at New Leaf Venture Partners; and Martin Hernon, a general partner at Boston...
BioCentury | Apr 3, 2006
Company News

Deltagen management update

Deltagen Inc. (DGEN), San Carlos, Calif. Business: Genomics, Functional genomics Promoted: Winston Thomas to COO from VP of operations; Shera Kash to VP from director of operations; and Robert Driscoll to president, CEO and secretary...
BioCentury | Jan 16, 2006
Company News

Charles River Laboratories Inc., Deltagen deal

...CRL received exclusive worldwide rights to supply Deltagen's repository materials for knockout mice. The repository includes...
...includes cryopreserved mouse embryos, sperm and ES cells. Charles River Laboratories Inc. (CRL), Wilmington, Mass. Deltagen Inc....
BioCentury | Oct 10, 2005
Company News

Deltagen, Lexicon Genetics Inc., National Institutes of Health genomics news

...LEXG and Deltagen will be made available to researchers at universities and other not-for-profit institutions. Deltagen Inc....
BioCentury | Sep 12, 2005
Company News

Deltagen, Stem Cell Sciences deal

...internal ribosome entry site) gene expression technology to manufacture, sell and sublicense knockout mice. Also, Deltagen...
...genetically engineered mice. STEM will receive $1.2 million up front and is eligible for royalties. Deltagen Inc....
BioCentury | Apr 4, 2005
Company News

Lexicon Genetics Inc., Deltagen functional genomics news

...The court overseeing Deltagen's bankruptcy proceedings awarded LEXG an initial payment of $4 million as part...
...of knockout mice that Deltagen generates going forward. Lexicon Genetics Inc. (LEXG), The Woodlands, Texas Deltagen Inc....
BioCentury | Sep 6, 2004
Strategy

Back to School 2004: Asset accumulation

...for hematopoietic and inflammatory diseases. The company also entered into a knockout mouse deal with Deltagen Inc....
...technology, gene database from internal efforts Knock-in mouse models from Kirin Knockout mouse models from Deltagen...
...technology, gene database from internal efforts Knock-in mouse models from Kirin Knockout mouse models from Deltagen...
Items per page:
1 - 10 of 144
BioCentury | May 16, 2011
Company News

Fluidigm sales and marketing update

Fluidigm launched its DELTAgene Assays for gene and single-cell expression, SNPtype Assays for SNP genotyping and target-specific primers for targeted resequencing worldwide. Fluidigm Corp. (NASDAQ:FLDM), South San Francisco, Calif. Business: Genomics WIR Staff...
BioCentury | Dec 21, 2009
Company News

Benten BioServices Inc., Deltagen deal

...Drug discovery company Deltagen acquired contract service company Benten in a stock deal valued at $1.1...
...acquired contract service company Benten in a stock deal valued at $1.1 million based on Deltagen's...
...close of $0.12 on Dec. 9, the last trading day before the deal was announced. Deltagen...
BioCentury | Mar 16, 2007
Company News

Roche returns rights to Trimeris' fusion inhibitor IP

...named E. Lawrence Hill acting president and COO. Hill is former CEO of genomics company Deltagen...
BioCentury | Apr 3, 2006
Company News

Deltagen board of directors update

Deltagen Inc. (DGEN), San Carlos, Calif. Business: Genomics, Functional genomics Appointed: Robert Driscoll, president, CEO and secretary; Philippe Chambon, a managing director at New Leaf Venture Partners; and Martin Hernon, a general partner at Boston...
BioCentury | Apr 3, 2006
Company News

Deltagen management update

Deltagen Inc. (DGEN), San Carlos, Calif. Business: Genomics, Functional genomics Promoted: Winston Thomas to COO from VP of operations; Shera Kash to VP from director of operations; and Robert Driscoll to president, CEO and secretary...
BioCentury | Jan 16, 2006
Company News

Charles River Laboratories Inc., Deltagen deal

...CRL received exclusive worldwide rights to supply Deltagen's repository materials for knockout mice. The repository includes...
...includes cryopreserved mouse embryos, sperm and ES cells. Charles River Laboratories Inc. (CRL), Wilmington, Mass. Deltagen Inc....
BioCentury | Oct 10, 2005
Company News

Deltagen, Lexicon Genetics Inc., National Institutes of Health genomics news

...LEXG and Deltagen will be made available to researchers at universities and other not-for-profit institutions. Deltagen Inc....
BioCentury | Sep 12, 2005
Company News

Deltagen, Stem Cell Sciences deal

...internal ribosome entry site) gene expression technology to manufacture, sell and sublicense knockout mice. Also, Deltagen...
...genetically engineered mice. STEM will receive $1.2 million up front and is eligible for royalties. Deltagen Inc....
BioCentury | Apr 4, 2005
Company News

Lexicon Genetics Inc., Deltagen functional genomics news

...The court overseeing Deltagen's bankruptcy proceedings awarded LEXG an initial payment of $4 million as part...
...of knockout mice that Deltagen generates going forward. Lexicon Genetics Inc. (LEXG), The Woodlands, Texas Deltagen Inc....
BioCentury | Sep 6, 2004
Strategy

Back to School 2004: Asset accumulation

...for hematopoietic and inflammatory diseases. The company also entered into a knockout mouse deal with Deltagen Inc....
...technology, gene database from internal efforts Knock-in mouse models from Kirin Knockout mouse models from Deltagen...
...technology, gene database from internal efforts Knock-in mouse models from Kirin Knockout mouse models from Deltagen...
Items per page:
1 - 10 of 144